Pharmacokinetics and bioequivalence of fudosteine granules and tablets in healthy volunteers
Yan Dong
Abstract
Yan Dong
Abstract
Objective: To evaluate the pharmacokinetics and bioequivalence of two preparations of fudosteine.Methods: In a randomized,crossover and self-control study,20 healthy male volunteers were given a single oral dose(400 mg) of test(granules) and reference(tables) prepatations.Serial plasma samples were analyzed by HPLC-MS/MS.Pharmacokinetic parameters were calculated and compared statistically to evaluated bioequivalence between the two preparations using DAS 2.1 program.Results: The major pharmacokinetic parameters of the reference and test preparations were as follows: Cmax(10.89±3.45) and(10.99±3.01) μg·mL-1,Tmax(0.43±0.09) and(0.38±0.14) h,t1/2(3.46±0.72) and(3.19±0.70) h,AUC0~t(23.17±7.47) and(23.17±6.64) μg·h·mL-1,AUC0~∞(25.13±7.63) and(24.97±6.94) μg·h·mL-1.The relative bioavailability of two preparations was(101.5±11.2) %.No significant differeneces between the two preparations were found in Cmax,Tmax and AUC.Conclusion: The test and reference preparations of fudosteine are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To evaluate the pharmacokinetics and bioequivalence of two preparations of fudosteine.Methods: In a randomized,crossover and self-control study,20 healthy male volunteers were given a single oral dose(400 mg) of test(granules) and reference(tables) prepatations.Serial plasma samples were analyzed by HPLC-MS/MS.Pharmacokinetic parameters were calculated and compared statistically to evaluated bioequivalence between the two preparations using DAS 2.1 program.Results: The major pharmacokinetic parameters of the reference and test preparations were as follows: Cmax(10.89±3.45) and(10.99±3.01) μg·mL-1,Tmax(0.43±0.09) and(0.38±0.14) h,t1/2(3.46±0.72) and(3.19±0.70) h,AUC0~t(23.17±7.47) and(23.17±6.64) μg·h·mL-1,AUC0~∞(25.13±7.63) and(24.97±6.94) μg·h·mL-1.The relative bioavailability of two preparations was(101.5±11.2) %.No significant differeneces between the two preparations were found in Cmax,Tmax and AUC.Conclusion: The test and reference preparations of fudosteine are bioequivalent.
Key concepts: Bioequivalence, Cmax, Pharmacokinetics, Bioavailability, Crossover study, Pharmacology, Medicine, High-performance liquid chromatography